L Bergeron

1.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

L Bergeron is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, L Bergeron has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in L Bergeron's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Tuberculosis Research and Epidemiology (2 papers). L Bergeron is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Tuberculosis Research and Epidemiology (2 papers). L Bergeron collaborates with scholars based in United States, Canada and Japan. L Bergeron's co-authors include Joseph Sodroski, Junying Yuan, Harry B. Greenberg, G. MacDonald, L Shi, Gloria I. Perez, Jonathan L. Tilly, Susannah Varmuza, Jodi A. Flaws and Hideaki Hara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Journal of Virology.

In The Last Decade

L Bergeron

13 papers receiving 1.3k citations

Hit Papers

Defects in regulation of apoptosis in caspase-2-deficient... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Bergeron United States 10 790 477 347 274 214 15 1.3k
Ling‐Jun Zhao United States 23 971 1.2× 701 1.5× 480 1.4× 439 1.6× 269 1.3× 62 1.9k
Wenchang Zhou China 7 452 0.6× 484 1.0× 363 1.0× 220 0.8× 180 0.8× 9 1.0k
M A Gonda United States 12 606 0.8× 665 1.4× 416 1.2× 345 1.3× 307 1.4× 17 1.6k
Masateru Hiyoshi Japan 16 493 0.6× 186 0.4× 397 1.1× 104 0.4× 64 0.3× 29 1.1k
Matjaž Barborič United States 19 1.4k 1.8× 663 1.4× 406 1.2× 310 1.1× 119 0.6× 23 1.9k
Shen Pang United States 21 783 1.0× 599 1.3× 322 0.9× 409 1.5× 212 1.0× 45 1.7k
Joëlle Boretto France 19 504 0.6× 556 1.2× 194 0.6× 647 2.4× 191 0.9× 24 1.2k
Donna M. D’Agostino Italy 26 938 1.2× 247 0.5× 935 2.7× 161 0.6× 189 0.9× 58 2.0k
Yuanfei Wu United States 14 584 0.7× 595 1.2× 350 1.0× 276 1.0× 339 1.6× 19 1.3k
Shaheen S. Sutterwala United States 9 241 0.3× 473 1.0× 631 1.8× 146 0.5× 260 1.2× 9 1.1k

Countries citing papers authored by L Bergeron

Since Specialization
Citations

This map shows the geographic impact of L Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Bergeron more than expected).

Fields of papers citing papers by L Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Bergeron. The network helps show where L Bergeron may publish in the future.

Co-authorship network of co-authors of L Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of L Bergeron. A scholar is included among the top collaborators of L Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Bergeron. L Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bergeron, L, et al.. (2024). Bridging the Gap in Carbohydrate Counting With a Mobile App: Needs Assessment Survey. Journal of Medical Internet Research. 27. e63278–e63278.
2.
Bernatsky, Sasha, John G. Hanly, Marie Hudson, et al.. (2010). Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatology International. 31(4). 549–554. 32 indexed citations
3.
Morita, Y., Daniel V. Maravei, L Bergeron, et al.. (2001). Caspase-2 deficiency prevents programmed germ cell death resulting from cytokine insufficiency but not meiotic defects caused by loss of ataxia telangiectasia-mutated (Atm) gene function. Cell Death and Differentiation. 8(6). 614–620. 58 indexed citations
4.
Bergeron, L, Gloria I. Perez, G. MacDonald, et al.. (1998). Defects in regulation of apoptosis in caspase-2-deficient mice. Genes & Development. 12(9). 1304–1314. 560 indexed citations breakdown →
5.
Johnson, A. L., J. T. Bridgham, L Bergeron, & Junying Yuan. (1997). Characterization of the avian Ich-1 cDNA and expression of Ich-1LmRNA in the hen ovary. Gene. 192(2). 227–233. 18 indexed citations
6.
Shi, L, G. MacDonald, L Bergeron, et al.. (1996). Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B.. Proceedings of the National Academy of Sciences. 93(20). 11002–11007. 74 indexed citations
7.
Cao, Jie, L Bergeron, Eirik Helseth, et al.. (1993). Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. Journal of Virology. 67(5). 2747–2755. 204 indexed citations
8.
Bergeron, L, Nancy Sullivan, & Joseph Sodroski. (1992). Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. Journal of Virology. 66(4). 2389–2397. 92 indexed citations
9.
Bergeron, L & Joseph Sodroski. (1992). Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. Journal of Virology. 66(10). 5777–5787. 44 indexed citations
10.
Kowalski, Mark, L Bergeron, Tatyana Dorfman, William A. Haseltine, & Joseph Sodroski. (1991). Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. Journal of Virology. 65(1). 281–291. 112 indexed citations
11.
Poznansky, Mark C., A. M. L. Lever, L Bergeron, W A Haseltine, & J G Sodroski. (1991). Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. Journal of Virology. 65(1). 532–536. 126 indexed citations
12.
Barden, Nicholas, L Bergeron, & Alan Betteridge. (1976). Effects of prostaglandin synthetase inhibitors and prostaglandin precursors on anterior pituitary cyclic AMP and hormone secretion.. PubMed. 1. 341–4. 1 indexed citations
13.
Bergeron, L & Nicholas Barden. (1975). Stimulation of cyclic AMP accumulation by arachidonic and 8, 11, 14-eicosatrienoic acids in rat anterior pituitary gland. Molecular and Cellular Endocrinology. 2(4). 253–260. 4 indexed citations
14.
Bergeron, L, et al.. (1951). [Two cases of reinfection of tertiary tuberculosis out of 7000 BCG vaccinations].. PubMed. 15(4-5). 382–92.
15.
Bergeron, L, et al.. (1951). [Efficacy of BCG in primary and post-primary tuberculosis in children and adolescents; experience in Montreuil].. PubMed. 15(12). 1084–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026